Microsteps Study-Short, Animated Storytelling Video
Short, Animated Storytelling Video and Written Messages to Promote Adoption of Health "Microsteps": an Online Randomized Experiment
1 other identifier
interventional
5,431
1 country
1
Brief Summary
This study evaluates the effect of single exposure to written Microsteps messages and short video booster content, on behavioral expectation to adopt behavioral nudges, in the immediate and medium term. Beyond that, the study will examine the effect of exposure to written Microsteps messages and short video booster content, on hope and happiness. This study will be conducted entirely online. Adult participants, in the US and the UK, will be recruited through the platform Prolific Academic (ProA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
June 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2025
CompletedJuly 23, 2025
July 1, 2025
18 days
May 2, 2025
July 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Effects of the written Microsteps, with instructional booster video or storytelling booster video, on behavioral expectation to adopt behavioral nudges, in the immediate and medium-term.
This measure is intended to explore the effect of the written messages, with two different approaches to the video booster, on behavioral expectation to adopt the Microsteps, in the immediate and medium-term. The Microsteps questionnaire consists of 8 questions, each measured on a Likert scale from 1-5 where 1 = very unlikely and 5 = very likely.
Baseline, immediately post-intervention exposure (up to 24 hours) and 2 weeks post exposure.
Secondary Outcomes (5)
Medium-term effects of the written Microsteps, with instructional booster video or storytelling booster video, on self-reported consumption of sweetened beverages.
Baseline, 2 weeks post intervention exposure
Medium-term effects of the written Microsteps, with instructional booster video or storytelling booster video, on self-reported consumption of dietary protein.
Baseline, 2 weeks post intervention exposure
Medium-term effects of the written Microsteps, with instructional booster video or storytelling booster video, on self-reported physical activity.
Baseline, 2 weeks post intervention exposure
Effects of the written Microsteps, with instructional booster video or storytelling booster video, on Hope
Baseline, immediately post intervention exposure (up to 24 hours) and 2 weeks post intervention exposure
Effects of the written Microsteps, with instructional booster video or storytelling booster video, on Happiness
Baseline, immediately post intervention exposure (up to 24 hours) and 2 weeks post intervention exposure
Study Arms (3)
Written messages of Microsteps and Instructional video
EXPERIMENTALParticipants will be shown written Microsteps messages presenting various behavioral nudges and a short instructional video. Thereafter, they will be asked to complete a questionnaire to assess their behavioral expectation of adopting the behavioral nudges and two visual analogue scales measuring hope and happiness. Two weeks later, participants will be invited to return and complete these outcome assessments again.
Written messages of Microsteps and Storytelling video
EXPERIMENTALParticipants will be shown written Microsteps messages presenting various behavioral nudges, as well as a short, animated storytelling video. Thereafter, they will be asked to complete the questionnaire assessing their behavioral expectation of adopting the behavioral nudges and two visual analogue scales measuring hope and happiness. Two weeks later, participants will be invited to return and complete these outcome assessments again.
Do-nothing Control Group
NO INTERVENTIONParticipants will not be exposed to either the microsteps or video content before they are asked to complete the questionnaire assessing their behavioral expectation of adopting the behavioral nudges and two visual analogue scales measuring hope and happiness. Two weeks later, participants will be invited to return and complete these outcome assessments again.
Interventions
Microsteps (behavioral nudges) are a series of short, written messages that were developed by the Thrive Global Wellbeing and Behavior Change Platform, based in the US. The Microsteps messages deliver step-wise, small health behavioral nudges that align with research on behavior change strategies. The behavioral nudges focus on health behaviors that could be useful adjunct interventions for GLP-1RA users, (improved food choices, exercise, sleep and stress management).
The storytelling video is a short, 2D animated, wordless storytelling video, of 2:21 minutes duration. The humorous, animated story features a minion-like character who, with the help of their dog, learns to adopt better health behaviors after experiencing an episode of burnout. The video mirrors the written Microsteps messages, conveying them through comical demonstration, rather than through instructional language. The animated characters are free of cultural identifiers, with the intention of increasing the accessibility of the video by overcoming barriers associated with culture, education, language and literacy. The video is intended to underscore and complement the written Microsteps messages, enhance their durability and boost hope and happiness in viewers.
The Instructional Video is a short 2:27min video demonstrating the microsteps and presenting additional information about the rationale for adopting them. The video features an educator who explains these points in a didactic format, and a second educator who demonstrates performing a microstep (stretching at a desk).
Eligibility Criteria
You may qualify if:
- Registered with the Prolific Academic platform
- Using a GLP-1RA medication or having used a GLP-1RA medication in the past.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maya Adam, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor in Department of Pediatrics
Study Record Dates
First Submitted
May 2, 2025
First Posted
May 13, 2025
Study Start
June 19, 2025
Primary Completion
July 7, 2025
Study Completion
July 21, 2025
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share